Zobrazeno 1 - 10
of 573
pro vyhledávání: '"Buller HR"'
Autor:
Brandjes DPM (AUTHOR), Buller HR (AUTHOR), Heijboer H (AUTHOR), Huisman MV (AUTHOR), de Rijk M (AUTHOR), Jagt H (AUTHOR), Wouter ten Cate J (AUTHOR)
Publikováno v:
Lancet. 3/15/1997, Vol. 349 Issue 9054, p759-762. 4p.
Autor:
Buller, Hr, Lensing, Aw, Prins, Mh, Agnelli, Giancarlo, Cohen, A, Gallus, As, Misselwitz, F, Raskob, G, Schellong, S, Segers, A, Einstein DVT Dose Ranging Study investigators
Publikováno v:
Flinders University PURE
Blood, 112(6), 2242-2247. American Society of Hematology
Blood, 112(6), 2242-2247. American Society of Hematology
We performed a randomized dose-ranging study, double-blind for rivaroxaban doses and open-label for the comparator (low-molecular-weight heparin followed by vitamin K antagonists) to assess the optimal dose of rivaroxaban for the treatment of deep ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8fd6a0edb2489008bd896bda5178d25
https://doi.org/10.1182/blood-2008-05-160143
https://doi.org/10.1182/blood-2008-05-160143
Autor:
Bauersachs, R, Berkowitz, SD, Brenner, B, Buller, HR, Decousus, H, Gallus, AS, Lensing, AW, Misselwitz, F, Prins, MH, Raskob, GE, Segers, A, Verhamme, P, Wells, P, Agnelli, G, Bounameaux, H, Cohen, A, Davidson, BL, Piovella, F, Schellong, S, Berkowitz, S, Büller, H, Gallus, A, Lensing, A, Peters, G, Prins, M, Raskob, G, et, al, DI MINNO, GIOVANNI
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2010, 363 (26), pp.2499-510. ⟨10.1056/NEJMoa1007903⟩
BASE-Bielefeld Academic Search Engine
Scott Berkowitz
New England journal of medicine, 363(26), 2499-2510. Massachussetts Medical Society
New England Journal of Medicine, 363(26), 2499-2510. MASSACHUSETTS MEDICAL SOCIETY
New England Journal of Medicine, Massachusetts Medical Society, 2010, 363 (26), pp.2499-510. ⟨10.1056/NEJMoa1007903⟩
BASE-Bielefeld Academic Search Engine
Scott Berkowitz
New England journal of medicine, 363(26), 2499-2510. Massachussetts Medical Society
New England Journal of Medicine, 363(26), 2499-2510. MASSACHUSETTS MEDICAL SOCIETY
Background: Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without the need for laboratory monitoring. Methods: We conducted an open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aaac9a3d4692271a8bdef42f443ebd6
http://hdl.handle.net/11391/174969
http://hdl.handle.net/11391/174969
Autor:
Bank, [No Value], Libourel, EJ, Middeldorp, S, Hamulyak, K, van Pampus, ECM, Koopman, MMW, Prins, MH, van der Meer, J, Buller, HR
Publikováno v:
Journal of Thrombosis and Haemostasis, 3(1), 79-84. Wiley
Elevated levels of coagulation factor VIII:C (FVIII:C) are associated with an increased risk for venous and arterial thromboembolism. Whether relatives of patients with elevated levels of FVIII:C are also at increased risk for thrombotic disease is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::911037ced7b18293f4ba60ac1c25aa8a
https://research.rug.nl/en/publications/49cd4e4f-e604-40f1-b954-5d461612a58b
https://research.rug.nl/en/publications/49cd4e4f-e604-40f1-b954-5d461612a58b